As of Jan 20
| -0.10 / -2.33%|
The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 21.50, with a high estimate of 33.00 and a low estimate of 15.00. The median estimate represents a +411.90% increase from the last price of 4.20.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.